Globe editorial
IRAQ WASN'T the only factor that decided congressional races last fall; embryonic stem cell research was a major issue, too. Polls consistently show public support of greater than 60 percent for broadening federal funding of experimentation with these cells, which have the potential to become any human tissue, advancing the treatment of diseases or injuries. (Full article: 468 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
